Announcements Trials
Browse Landscape

Phase

Phase 1/2 4

Status

Unknown 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 439Neoplasms 364Breast Neoplasms 261Colorectal Neoplasms 245Neoplasm Metastasis 217Melanoma 210Leukemia, Myeloid, Acute 188Multiple Myeloma 187Pancreatic Neoplasms 183Ovarian Neoplasms 181Recurrence 175Prostatic Neoplasms 161Lymphoma, Non-Hodgkin 142Stomach Neoplasms 133Squamous Cell Carcinoma of Head and Neck 128Lung Neoplasms 126Lymphoma 121Carcinoma, Hepatocellular 117Carcinoma, Renal Cell 102Triple Negative Breast Neoplasms 100Leukemia, Lymphocytic, Chronic, B-Cell 99Glioblastoma 98Advanced Solid Tumor 94Leukemia 93Small Cell Lung Carcinoma 91Lymphoma, Large B-Cell, Diffuse 90Head and Neck Neoplasms 87Advanced Solid Tumors 85Endometrial Neoplasms 81Myelodysplastic Syndromes 78

Interventions

Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × INDUSTRY × Precision Cell Immunotherapy × Clear all
NCT02873416 2016-10-07

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled
Thoracic

Precision Cell Immunotherapy

NCT02873442 2016-10-07

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled

Precision Cell Immunotherapy

NCT02873520 2016-10-07

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Precision Cell Immunotherapy

NCT02862561 2016-09-02

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Shanghai International Medical Center

Phase 1/2 Unknown
40 enrolled

Precision Cell Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡